Andreessen Horowitz has shifted its digital health investment strategy to focus on earlier-stage deals. We look at where it has placed its recent bets.
Over 20,000 founders applied to Y Combinator's Winter 2023 cohort. We analyze the 20 healthcare companies that made the cut.
Global digital health funding holds steady at $3.4B in Q1’23 after plummeting for 4 straight quarters.
We mined CB Insights business relationship data on Pfizer to highlight who it’s working with and distill its areas of strategic focus.
We mined Cigna’s acquisitions, investments, and partnerships to discern the company's strategic priorities.
From patient data exchanges to developer toolkits, these vendors are working across tech markets to make healthcare data more accessible.
We mined Novartis’ acquisitions, investments, and partnerships to discern the company's strategic priorities.
Global digital health investment activity contracted in 2022, with funding falling by 57% year-over-year and deals reaching a 5-year low.
We outline the market outlook for patient-directed scheduling and navigation in the healthcare industry — from investment trends, to leading companies, to recommendations for the players in the space.
As payers look for innovative ways to improve care at a lower cost, Cigna and Elevance Health (formerly Anthem) are exploring opportunities in digital therapeutics.
The Digital Health 150 is CB Insights' annual ranking of the 150 most promising digital health startups in the world. This year's winning companies include startups working on interoperability and data integration, home care and monitoring, AR/VR in healthcare, hybrid care, and more.
We outline the market outlook for remote monitoring in home healthcare delivery — from investment trends, to leading companies, to recommendations for the players in the space.
Providers are finally starting to see the benefits of new rules governing health data management to drive interoperability. This Market Map explores the companies helping providers navigate this newly open ecosystem.
We outline the market outlook for virtual care in the healthcare industry — from investment trends, to leading companies, to recommendations for the players in the space.
Global population aging is putting pressure on providers. From treating chronic conditions to enabling hospital-at-home models, this Market Map looks at the companies developing technology for senior care.
We outline the market outlook for anxiety and depression digital therapeutics in healthcare — from investment trends, to leading companies, to recommendations for players in the space.
By providing everything from enhanced diagnostics to therapeutic teddy bears, these companies are changing the way diabetes is treated.
We outline the market outlook for diabetes digital therapeutics in healthcare — from investment trends, to leading companies, to recommendations for players in the space.
From AI-powered drug discovery to quantum computing, this MVP Technology Framework evaluates the tech solutions pharmaceutical companies and contract research organizations (CROs) like Pfizer and IQVIA are using to improve drug discovery.
The global digital health market continues its decline in Q3’22 as funding decreases 36% quarter-over-quarter.
From next-gen diagnostics platforms to digital operating room tools, new technologies are reimagining how providers deliver care at the hospital.
From remote monitoring to care coordination, this MVP Technology Framework evaluates the technologies that healthcare leaders like Humana and UnitedHealth Group are using to enhance member engagement and promote better healthcare outcomes.
From contract management to population health, we evaluate and prioritize technologies for healthcare payers to consider in value-based care.
With per-member spending for healthcare services rising, this Tech Market Map looks at the companies helping healthcare payers offer innovative services to reduce costs and support long-term member health.
We mined Optum's acquisitions, investments, and partnerships to discern the company's strategic priorities.